SCHEMBL30954043

SCHEMBL30954043

COc1c(Cl)cc2c(c1C(=O)O)OCCCN2C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 2/20 0.37
TPMT P51580 1/20 0.36
DRD3 P35462 10/20 0.35
DRD2 P14416 8/20 0.35
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
TAS1R2 Q8TE23 1/20 0.34
DRD4 P21917 5/20 0.34
HTR1A P08908 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
DRD1 P21728 4/20 0.34
DRD5 P21918 4/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27432942 1.00 KDM4E (0.41) KDM4EHSD17B10ALDH1A1MAPTTPMT
SCHEMBL30954108 0.93 KDM4E (0.43) KDM4EHSD17B10ALDH1A1MAPTTPMT
SCHEMBL27432464 0.93 KDM4E (0.43) KDM4EHSD17B10ALDH1A1MAPTTPMT
SCHEMBL27432939 0.89 MAPT (0.38) KDM4EHSD17B10ALDH1A1MAPTDRD3
SCHEMBL30954080 0.87 HSD17B10 (0.42) HSD17B10ALDH1A1MAPTDRD2KMT2A
SCHEMBL27432967 0.87 HSD17B10 (0.42) HSD17B10ALDH1A1MAPTDRD2KMT2A
SCHEMBL30954143 0.84 RORC (0.37) KDM4EMAPTDRD2CYP1A2CYP2C19
SCHEMBL27433032 0.84 RORC (0.37) KDM4EMAPTDRD2CYP1A2CYP2C19
SCHEMBL27434460 0.80 RXFP1 (0.42) KDM4EHSD17B10ALDH1A1KMT2A
SCHEMBL30954070 0.80 S1PR1 (0.34) ALDH1A1MAPTDRD2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP claimed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO claimed
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed